Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Dodel

Showing results (201-210 of 250) with videos related to

Pageof 25
Sort By:
Methods and Protocols|September 23, 2024
The Burden of Sleep/Wake Disorders: Excessive Daytime Sleepiness and Insomnia ProjectMarina Tüzün, Ulf Kallweit, Stefan Seidel, et al.
Epilepsia|October 19, 2016
Costs and cost-driving factors for acute treatment of adults with status epilepticus: A multicenter cohort study from GermanyLena-Marie Kortland, Anne Alfter, Oliver Bähr, et al.
Journal of Neuroinflammation|December 3, 2024
Autoantibody profiles in Alzheimer´s, Parkinson´s, and dementia with Lewy bodies: altered IgG affinity and IgG/IgM/IgA responses to alpha-synuclein, amyloid-beta, and tau in disease-specific pathological patternsLuisa Knecht, Katrine Dalsbøl, Anja Hviid Simonsen, et al.
Epilepsia|August 4, 2015
Costs of epilepsy and cost-driving factors in children, adolescents, and their caregivers in GermanyJanna Riechmann, Adam Strzelczyk, Jens P Reese, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 1, 2023
Fc N-glycosylation of autoreactive Aβ antibodies as a blood-based biomarker for Alzheimer's diseaseYannick Kronimus, Alexandra Albus, Mike Hasenberg, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 13, 2010
Safety and efficacy of perampanel in advanced Parkinson's disease: a randomized, placebo-controlled studyKarla Eggert, David Squillacote, Paolo Barone, et al.
Neurobiology of Aging|October 14, 2021
Brain age and Alzheimer's-like atrophy are domain-specific predictors of cognitive impairment in Parkinson's diseaseDaniel Charissé, Guray Erus, Raymond Pomponio, et al.
Alzheimer'S Research & Therapy|March 25, 2017
Structured relearning of activities of daily living in dementia: the randomized controlled REDALI-DEM trial on errorless learningSebastian Voigt-Radloff, Maartje M E de Werd, Rainer Leonhart, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 6, 2026
Transthyretin stabilizer therapy increases naturally-occurring antibodies in ATTR cardiomyopathyStephan Settelmeier, Daniel Agranovski, Maximilian Steinhardt, et al.
Movement Disorders Clinical Practice|July 7, 2020
The Prevalence and Determinants of Neuropsychiatric Symptoms in Late-Stage ParkinsonismAdrianus L A J Hommel, Marjan J Meinders, Stefan Lorenzl, et al.
Pageof 25

Showing results (201-210 of 250) with videos related to

Sort By:
Pageof 25
Methods and Protocols|September 23, 2024
The Burden of Sleep/Wake Disorders: Excessive Daytime Sleepiness and Insomnia ProjectMarina Tüzün, Ulf Kallweit, Stefan Seidel, et al.
Epilepsia|October 19, 2016
Costs and cost-driving factors for acute treatment of adults with status epilepticus: A multicenter cohort study from GermanyLena-Marie Kortland, Anne Alfter, Oliver Bähr, et al.
Journal of Neuroinflammation|December 3, 2024
Autoantibody profiles in Alzheimer´s, Parkinson´s, and dementia with Lewy bodies: altered IgG affinity and IgG/IgM/IgA responses to alpha-synuclein, amyloid-beta, and tau in disease-specific pathological patternsLuisa Knecht, Katrine Dalsbøl, Anja Hviid Simonsen, et al.
Epilepsia|August 4, 2015
Costs of epilepsy and cost-driving factors in children, adolescents, and their caregivers in GermanyJanna Riechmann, Adam Strzelczyk, Jens P Reese, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 1, 2023
Fc N-glycosylation of autoreactive Aβ antibodies as a blood-based biomarker for Alzheimer's diseaseYannick Kronimus, Alexandra Albus, Mike Hasenberg, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 13, 2010
Safety and efficacy of perampanel in advanced Parkinson's disease: a randomized, placebo-controlled studyKarla Eggert, David Squillacote, Paolo Barone, et al.
Neurobiology of Aging|October 14, 2021
Brain age and Alzheimer's-like atrophy are domain-specific predictors of cognitive impairment in Parkinson's diseaseDaniel Charissé, Guray Erus, Raymond Pomponio, et al.
Alzheimer'S Research & Therapy|March 25, 2017
Structured relearning of activities of daily living in dementia: the randomized controlled REDALI-DEM trial on errorless learningSebastian Voigt-Radloff, Maartje M E de Werd, Rainer Leonhart, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 6, 2026
Transthyretin stabilizer therapy increases naturally-occurring antibodies in ATTR cardiomyopathyStephan Settelmeier, Daniel Agranovski, Maximilian Steinhardt, et al.
Movement Disorders Clinical Practice|July 7, 2020
The Prevalence and Determinants of Neuropsychiatric Symptoms in Late-Stage ParkinsonismAdrianus L A J Hommel, Marjan J Meinders, Stefan Lorenzl, et al.
Pageof 25